Syncom Formulations (India) Limited (SYNCOMF.NS)
INR 21.04
(-0.14%)
INR 21.04
(-0.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 249.25 Million INR | 63.77% |
| 2022 | 152.19 Million INR | -4.8% |
| 2021 | 159.87 Million INR | -52.71% |
| 2020 | 338.03 Million INR | 166.89% |
| 2019 | 126.65 Million INR | 61.55% |
| 2018 | 78.4 Million INR | -1.68% |
| 2017 | 79.74 Million INR | -41.73% |
| 2016 | 136.84 Million INR | -9.71% |
| 2015 | 151.57 Million INR | 0.16% |
| 2014 | 151.32 Million INR | 12.25% |
| 2013 | 134.8 Million INR | 59.55% |
| 2012 | 84.49 Million INR | 43.75% |
| 2011 | 58.77 Million INR | 518.78% |
| 2010 | 9.49 Million INR | -87.14% |
| 2009 | 73.87 Million INR | 21.58% |
| 2008 | 60.76 Million INR | 0.97% |
| 2007 | 60.18 Million INR | -13.82% |
| 2006 | 69.83 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 91.54 Million INR | 12.64% |
| 2023 Q1 | 53.59 Million INR | -53.65% |
| 2023 FY | 249.25 Million INR | 63.77% |
| 2023 Q4 | 81.26 Million INR | 37.48% |
| 2023 Q3 | 59.11 Million INR | -37.94% |
| 2023 Q2 | 95.24 Million INR | 77.71% |
| 2022 Q3 | 66.82 Million INR | 11.74% |
| 2022 FY | 152.19 Million INR | -4.8% |
| 2022 Q1 | 24.91 Million INR | -5.76% |
| 2022 Q2 | 59.8 Million INR | 140.01% |
| 2022 Q4 | 115.63 Million INR | 73.04% |
| 2021 Q4 | 26.43 Million INR | -32.34% |
| 2021 Q1 | 60.27 Million INR | -28.89% |
| 2021 Q2 | 46.95 Million INR | -22.1% |
| 2021 FY | 159.87 Million INR | -52.71% |
| 2021 Q3 | 39.07 Million INR | -16.79% |
| 2020 Q2 | 112.64 Million INR | 260.75% |
| 2020 FY | 338.03 Million INR | 166.89% |
| 2020 Q4 | 84.76 Million INR | -29.68% |
| 2020 Q3 | 120.54 Million INR | 7.01% |
| 2020 Q1 | 31.22 Million INR | 18.76% |
| 2019 FY | 126.65 Million INR | 61.55% |
| 2019 Q4 | 26.29 Million INR | -20.26% |
| 2019 Q3 | 32.97 Million INR | -17.21% |
| 2019 Q2 | 39.82 Million INR | 45.55% |
| 2019 Q1 | 27.36 Million INR | 44.93% |
| 2018 FY | 78.4 Million INR | -1.68% |
| 2018 Q4 | 18.87 Million INR | -27.54% |
| 2018 Q3 | 26.05 Million INR | -1.34% |
| 2018 Q2 | 26.4 Million INR | 275.5% |
| 2018 Q1 | 7.03 Million INR | -32.63% |
| 2017 Q1 | 24.89 Million INR | -10.05% |
| 2017 FY | 79.74 Million INR | -41.73% |
| 2017 Q4 | 10.43 Million INR | -59.46% |
| 2017 Q3 | 25.75 Million INR | 40.41% |
| 2017 Q2 | 18.34 Million INR | -26.33% |
| 2016 FY | 136.84 Million INR | -9.71% |
| 2016 Q4 | 27.67 Million INR | 0.0% |
| 2016 Q1 | 37.79 Million INR | 37.43% |
| 2015 Q4 | 27.5 Million INR | -40.6% |
| 2015 Q3 | 46.3 Million INR | -6.68% |
| 2015 Q2 | 49.61 Million INR | 76.22% |
| 2015 FY | 151.57 Million INR | 0.16% |
| 2015 Q1 | 28.15 Million INR | -12.86% |
| 2014 Q4 | 32.3 Million INR | -38.5% |
| 2014 Q3 | 52.53 Million INR | 16.98% |
| 2014 Q2 | 44.9 Million INR | 108.11% |
| 2014 Q1 | 21.57 Million INR | -46.14% |
| 2014 FY | 151.32 Million INR | 12.25% |
| 2013 Q1 | 22.75 Million INR | 62.54% |
| 2013 Q4 | 40.06 Million INR | -1.41% |
| 2013 Q3 | 40.63 Million INR | 29.63% |
| 2013 Q2 | 31.35 Million INR | 37.79% |
| 2013 FY | 134.8 Million INR | 59.55% |
| 2012 Q3 | 33.88 Million INR | 20.0% |
| 2012 Q4 | 13.99 Million INR | -58.69% |
| 2012 FY | 84.49 Million INR | 43.75% |
| 2012 Q1 | 1.67 Million INR | 0.0% |
| 2012 Q2 | 28.23 Million INR | 1582.9% |
| 2011 FY | 58.77 Million INR | 518.78% |
| 2010 FY | 9.49 Million INR | -87.14% |
| 2009 FY | 73.87 Million INR | 21.58% |
| 2008 FY | 60.76 Million INR | 0.97% |
| 2007 FY | 60.18 Million INR | -13.82% |
| 2006 FY | 69.83 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | 83.089% |
| Ind-Swift Limited | 1.22 Billion INR | 79.669% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | 49.698% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 99.761% |
| Innova Captab Limited | 2.53 Billion INR | 90.161% |
| Divi's Laboratories Limited | 18.31 Billion INR | 98.639% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 94.429% |
| Morepen Laboratories Limited | 4.17 Billion INR | 94.028% |
| Mankind Pharma Limited | 40.86 Billion INR | 99.39% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | 85.4% |
| Laurus Labs Limited | 3.94 Billion INR | 93.688% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 93.593% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 97.224% |
| Alembic Limited | 767.77 Million INR | 67.536% |
| Hikal Limited | 1.49 Billion INR | 83.319% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 95.671% |
| Neuland Laboratories Limited | 5.31 Billion INR | 95.313% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 96.695% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 96.167% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 94.957% |
| Themis Medicare Limited | 1.3 Billion INR | 80.873% |
| RPG Life Sciences Limited | 2.29 Billion INR | 89.127% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 99.451% |
| Lupin Limited | 27.75 Billion INR | 99.102% |
| Amrutanjan Health Care Limited | 621.02 Million INR | 59.865% |
| Wockhardt Limited | 140 Million INR | -78.036% |
| Vaishali Pharma Limited | 6.29 Million INR | -3860.137% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 92.032% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -16.451% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 95.197% |
| FDC Limited | 3.03 Billion INR | 91.784% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.632% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -19.803% |
| Eris Lifesciences Limited | 5.18 Billion INR | 95.19% |
| Venus Remedies Limited | 534.65 Million INR | 53.381% |
| ZIM Laboratories Limited | 1.09 Billion INR | 77.302% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 79.752% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | 54.812% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 96.55% |
| Shilpa Medicare Limited | 3.76 Billion INR | 93.374% |
| Albert David Limited | 1.33 Billion INR | 81.322% |
| Ajanta Pharma Limited | 19.67 Billion INR | 98.733% |
| Hester Biosciences Limited | 364.77 Million INR | 31.669% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 94.59% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 106.469% |
| Gufic Biosciences Limited | 2.89 Billion INR | 91.387% |
| Windlas Biotech Limited | 1.29 Billion INR | 80.81% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 91.053% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -8704.886% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -807.754% |
| Granules India Limited | 6.52 Billion INR | 96.182% |
| Aarti Drugs Limited | 7.14 Billion INR | 96.513% |
| Bal Pharma Limited | 214.56 Million INR | -16.164% |
| Alkem Laboratories Limited | 19.46 Billion INR | 98.719% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.761% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 86.925% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -4.877% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -1106.676% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | 89.443% |
| Medico Remedies Limited | 277.11 Million INR | 10.056% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 87.593% |
| Ipca Laboratories Limited | 29.59 Billion INR | 99.158% |
| Brooks Laboratories Limited | -72.25 Million INR | 444.975% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 99.016% |
| NATCO Pharma Limited | 25.96 Billion INR | 99.04% |
| Suven Life Sciences Limited | -1.22 Billion INR | 120.333% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 95.23% |
| Indoco Remedies Limited | 1.52 Billion INR | 83.649% |
| Alpa Laboratories Limited | 61.51 Million INR | -305.187% |
| Lasa Supergenerics Limited | -458 Million INR | 154.421% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 106.057% |